von Bubnoff, D., Schmitt, C., Goldinger, S. M., Schadendorf, D., Kähler, K. C., Hafner, C., . . . Heinzerling, L. (2025). Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab. PLoS ONE, 20(5), 1. https://doi.org/10.1371/journal.pone.0321937
Chicago Style (17th ed.) Citationvon Bubnoff, Dagmar, et al. "Prognostic and Predictive Value of IDO Expression in Metastatic Melanoma Treated with Ipilimumab." PLoS ONE 20, no. 5 (2025): 1. https://doi.org/10.1371/journal.pone.0321937.
MLA (9th ed.) Citationvon Bubnoff, Dagmar, et al. "Prognostic and Predictive Value of IDO Expression in Metastatic Melanoma Treated with Ipilimumab." PLoS ONE, vol. 20, no. 5, 2025, p. 1, https://doi.org/10.1371/journal.pone.0321937.